User:20ogk1/sandbox
Welcome to your sandbox!
Link to Project Resource Page
[edit]Project Homepage and Resources
Practice Editing Here (Nov 15th in-class Wiki session work)
[edit]- This is a place to practice clicking the "edit" button and practice adding references (via the citation button).
Task:
- Find a peer-reviewed journal article on PubMed. Practice inserting your citation in the above space using the "cite" tool
- Choose one "B-level" medical article on Wikipedia from the following list: https://wp1.openzim.org/#/project/Medicine/articles?quality=B-Class&importance=High-Class
- Practice editing live on Wikipedia by finding a typo in the text or improving the clarity/readability of a sentence by adjusting a few words in a sentence.
Assignment # 3- please post an anonymous copy here!
[edit]1. Suggested Change #5: "Diagnosis" section, "Classification" heading.
- Suggested change: All amyloid fibril proteins start with the letter "A" followed by the protein suffix (and any applicable specification). See below for a list of amyloid fibril proteins which have been found in humans:[1]
Fibril protein | Precursor protein | Target Organs | Systemic and/or localized | Acquired or hereditary |
---|---|---|---|---|
AL | Immunoglobulin light chain | All organs, usually except CNS | S, L | A, H |
AH | Immunoglobulin heavy chain | All organs except CNS | S, L | A |
AA | (Apo) serum amyloid A | All organs except CNS | S | A |
ATTR | Transthyretin, wild type
|
Heart mainly in males, lung, ligaments, tenosynovium
|
S
|
A
|
Aβ2M | β2-microglobulin, wild type
|
Musculoskeletal system
|
S
|
A
|
AApoAI | Apolipoprotein A I, variants | Heart, liver, kidney, PNS, testis, larynx (C
terminal variants), skin (C terminal variants) |
S | H |
AApoAII | Apolipoprotein A II, variants | Kidney | S | H |
AApoAIV | Apolipoprotein A IV, wild type | Kidney medulla and systemic | S | A |
AApoCII | Apolipoprotein C II, variants | Kidney | S | H |
AApoCIII | Apolipoprotein C III, variants | Kidney | S | H |
AGel | Gelsolin, variants | Kidney, PNS, cornea | S | H |
ALys | Lysozyme, variants | Kidney | S | H |
ALECT2 | Leukocyte chemotactic factor-2 | Kidney, primarily | S | A |
AFib | Fibrinogen a, variants | Kidney, primarily | S | H |
ACys | Cystatin C, variants | CNS, PNS, skin | S | H |
ABri | ABriPP, variants | CNS | S | H |
ADanb | ADanPP, variants | CNS | L | H |
Aβ | Aβ protein precursor, wild type
|
CNS | L
|
A
|
AαSyn | α-Synuclein | CNS | L | A |
ATau | Tau | CNS | L | A |
APrP | Prion protein, wild type
|
CJD, fatal insomnia
|
L
|
A
|
ACal | (Pro)calcitonin | C-cell thyroid tumours
|
L
|
A
|
AIAPP | Islet amyloid polypeptidec | Islets of Langerhans, insulinomas | L | A |
AANF | Atrial natriuretic factor | Cardiac atria | L | A |
APro | Prolactin | Pituitary prolactinomas, aging pituitary | L | A |
AIns | Insulin | Iatrogenic, local injection | L | A |
ASPCd | Lung surfactant protein | Lung | L | A |
ACor | Corneodesmosin | Cornified epithelia, hair follicles | L | A |
AMed | Lactadherin | Senile aortic, media | L | A |
AKer | Kerato-epithelin | Cornea, hereditary | L | A |
ALac | Lactoferrin | Cornea | L | A |
AOAAP | Odontogenic ameloblast-associated protein | Odontogenic tumours | L | A |
ASem1 | Semenogelin 1 | Vesicula seminalis | L | A |
AEnf | Enfurvitide | Iatrogenic | L | A |
ACatKe | Cathepsin K | Tumour associated | L | A |
AEFEMP1e | EGF-containing fibulin-like extracellular
matrix protein 1 (EFEMP1) |
Portal veins, Aging associated | L | A |
20ogk1 (talk) 03:29, 18 November 2021 (UTC)
2. Rationale: The International Society of Amyloidosis (ISA) Nomenclature Committee meets every 2 years to discuss and update classifications. Due to the ongoing research surrounding amyloids, it is critical for Wikipedia to reflect the most up-to-date types of amyloid fibril proteins and their associated areas of deposit.
3. Controversy: No controversy was identified with this area as the previous nomenclature did not have a reference.
4. Critique of Sources: The main strength of the source is that the ISA currently stands as the premier resource concerning amyloid nomenclature consensus. The authors come from all around the world, and represent independent and unbiased expertise. It is also the most up-to-date and comprehensive list I found available. The weakness of the source is that the list of precursor proteins is difficult to understand for those without a background in medicine or bioscience. I have also removed the previous table's column attempting to relate each fibril to a disease, as this was not properly referenced. This is somewhat unavoidable when discussing amyloidosis, as many relationships between amyloid deposits and diseases are still not entirely understood.
5. Wikipedia Talk Page: The above recommended change has been posted to the Amyloidosis "talk" page on Wikipedia.
What to post on the Wikipedia article talk page (part of assignment 3)
[edit]- This will also be covered on Nov 15th in class. Your group should use the below template to share an outline of your proposed improvements (including your new wording and citations). Article talk pages are not places to share your assignment answers. The Wikipedia community will be more interested in viewing your exact article improvement suggestions including where you plan to improve the article (which section), what wording you suggest, and the exact citation (Note: all citations must meet WP:MEDRS)
- You will not be able to paste citations directly from your sandbox to talk pages (unless you are interested in editing/learning Wiki-code in the "source editing" mode). We suggest re-adding your citations on the talk page manually (using the cite button and populating the citation by pasting in the DOI, website, or PMID). You will have to repeat this process yet again when you edit the actual article live.
- Talk Page Template: Wikipedia:CARL Medical Editing Initiative/Fall 2021/Talk Page Template
- ^ Benson, Merrill D.; Buxbaum, Joel N.; Eisenberg, David S.; Merlini, Giampaolo; Saraiva, Maria J. M.; Sekijima, Yoshiki; Sipe, Jean D.; Westermark, Per (2020-10-01). "Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee". Amyloid. 27 (4): 217–222. doi:10.1080/13506129.2020.1835263. ISSN 1350-6129.